Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

CD90 is used as a marker for cancer stem cell in liver cancer. We aimed to study the mechanism by which CD90 promoted liver cancer progression and identify the new therapeutic targets on CD90 signal pathway. Ectopic expression of CD90 in liver cancer cell lines enhanced anchorage-independent growth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chen, Wei-Ching, Chang, Yung-Sheng, Hsu, Hui-Ping, Yen, Meng-Chi, Huang, Hau-Lun, Cho, Chien-Yu, Wang, Chih-Yang, Weng, Tzu-Yang, Lai, Po-Ting, Chen, Ching-Shih, Lin, Yih-Jyh, Lai, Ming-Derg
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767481/
https://ncbi.nlm.nih.gov/pubmed/26556861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados